Investigational TKI Shows Promise For Treating Castration-Resistant Prostate Cancer

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Regular Member

Date Joined Mar 2010
Total Posts : 134
   Posted 6/10/2011 7:43 AM (GMT -6)   
Although its still in trials and approval takes quite a while, here's some good news.

Investigational TKI Shows Promise For Treating Castration-Resistant Prostate Cancer.

MedPage Today (6/9, Bankhead) reported that two-thirds of men with "castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor (TKI)," according to findings presented at the American Society for Clinical Oncology meeting. Data from a randomized trial showed that between "two-thirds and three-fourths of patients had measurable disease regression, complete or partial resolution of bone lesions, and improvement in pain." The patients had a "median progression-free survival (PFS) of 29 weeks, which included a threefold improvement in PFS in a small group of patients randomized to cabozantinib or placebo. 'In patients with progressive metastatic castration-resistant prostate cancer, cabozantinib has substantial antitumor activity,'" noted the lead study author.
52 at Dx (3/12/10), father died of PCa
PSA: 10/16/09 - 2.8; 1/11/10 - 3.8; since RALP - <0.1
RALP 5/19/10, Dr. Lee, U. Penn Presby
Gleason 6, gland involvement < 2%; tumor in peripheral zone both sides; no capsular, extracapsular extension, lymph node, or seminal vesical involvement; no positive margins
Incontinence: no pads except at karate
ED: pump. Levitra 10mg every other night
New Topic Post Reply Printable Version
Forum Information
Currently it is Wednesday, September 19, 2018 5:41 AM (GMT -6)
There are a total of 3,004,546 posts in 329,153 threads.
View Active Threads

Who's Online
This forum has 161744 registered members. Please welcome our newest member, csorthofeet.
233 Guest(s), 5 Registered Member(s) are currently online.  Details
TAD4207, Gemlin, ceebs13, Lightlife, Mamatomypeas